Keywords: Novartis, UK, Job losses, Respiratory research, Manufacturing, Restructuring

Novartis UK proposes slashing Horsham site operations; 500 job losses

Article | 17 March 2011

Print This

In another blow to the UK pharmaceutical sector, the local subsidiary of Swiss drug major Novartis (NOVN: VX) announced that ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in